These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 37288658)

  • 1. Targeting myocardial equilibrative nucleoside transporter ENT1 provides cardioprotection by enhancing myeloid Adora2b signaling.
    Ruan W; Li J; Choi S; Ma X; Liang Y; Nair R; Yuan X; Mills TW; Eltzschig HK
    JCI Insight; 2023 Jun; 8(11):. PubMed ID: 37288658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Equilibrative nucleoside transporter (ENT)-1-dependent elevation of extracellular adenosine protects the liver during ischemia and reperfusion.
    Zimmerman MA; Tak E; Ehrentraut SF; Kaplan M; Giebler A; Weng T; Choi DS; Blackburn MR; Kam I; Eltzschig HK; Grenz A
    Hepatology; 2013 Nov; 58(5):1766-78. PubMed ID: 23703920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crosstalk between the equilibrative nucleoside transporter ENT2 and alveolar Adora2b adenosine receptors dampens acute lung injury.
    Eckle T; Hughes K; Ehrentraut H; Brodsky KS; Rosenberger P; Choi DS; Ravid K; Weng T; Xia Y; Blackburn MR; Eltzschig HK
    FASEB J; 2013 Aug; 27(8):3078-89. PubMed ID: 23603835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Equilibrative nucleoside transporter 1 (ENT1) regulates postischemic blood flow during acute kidney injury in mice.
    Grenz A; Bauerle JD; Dalton JH; Ridyard D; Badulak A; Tak E; McNamee EN; Clambey E; Moldovan R; Reyes G; Klawitter J; Ambler K; Magee K; Christians U; Brodsky KS; Ravid K; Choi DS; Wen J; Lukashev D; Blackburn MR; Osswald H; Coe IR; Nürnberg B; Haase VH; Xia Y; Sitkovsky M; Eltzschig HK
    J Clin Invest; 2012 Feb; 122(2):693-710. PubMed ID: 22269324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coordination of ENT2-dependent adenosine transport and signaling dampens mucosal inflammation.
    Aherne CM; Collins CB; Rapp CR; Olli KE; Perrenoud L; Jedlicka P; Bowser JL; Mills TW; Karmouty-Quintana H; Blackburn MR; Eltzschig HK
    JCI Insight; 2018 Oct; 3(20):. PubMed ID: 30333323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential Tissue-Specific Function of Adora2b in Cardioprotection.
    Seo SW; Koeppen M; Bonney S; Gobel M; Thayer M; Harter PN; Ravid K; Eltzschig HK; Mittelbronn M; Walker L; Eckle T
    J Immunol; 2015 Aug; 195(4):1732-43. PubMed ID: 26136425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Equilibrative nucleoside transporter 1 plays an essential role in cardioprotection.
    Rose JB; Naydenova Z; Bang A; Eguchi M; Sweeney G; Choi DS; Hammond JR; Coe IR
    Am J Physiol Heart Circ Physiol; 2010 Mar; 298(3):H771-7. PubMed ID: 20035027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancing Extracellular Adenosine Levels Restores Barrier Function in Acute Lung Injury Through Expression of Focal Adhesion Proteins.
    Wang W; Chen NY; Ren D; Davies J; Philip K; Eltzschig HK; Blackburn MR; Akkanti B; Karmouty-Quintana H; Weng T
    Front Mol Biosci; 2021; 8():636678. PubMed ID: 33778007
    [No Abstract]   [Full Text] [Related]  

  • 9. Repression of the equilibrative nucleoside transporters dampens inflammatory lung injury.
    Morote-Garcia JC; Köhler D; Roth JM; Mirakaj V; Eldh T; Eltzschig HK; Rosenberger P
    Am J Respir Cell Mol Biol; 2013 Aug; 49(2):296-305. PubMed ID: 23590299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absence of equilibrative nucleoside transporter 1 in ENT1 knockout mice leads to altered nucleoside levels following hypoxic challenge.
    Rose JB; Naydenova Z; Bang A; Ramadan A; Klawitter J; Schram K; Sweeney G; Grenz A; Eltzschig H; Hammond J; Choi DS; Coe IR
    Life Sci; 2011 Oct; 89(17-18):621-30. PubMed ID: 21872611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adora2b signaling on bone marrow derived cells dampens myocardial ischemia-reperfusion injury.
    Koeppen M; Harter PN; Bonney S; Bonney M; Reithel S; Zachskorn C; Mittelbronn M; Eckle T
    Anesthesiology; 2012 Jun; 116(6):1245-57. PubMed ID: 22531331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alveolar Epithelial A2B Adenosine Receptors in Pulmonary Protection during Acute Lung Injury.
    Hoegl S; Brodsky KS; Blackburn MR; Karmouty-Quintana H; Zwissler B; Eltzschig HK
    J Immunol; 2015 Aug; 195(4):1815-24. PubMed ID: 26188061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoxanthine uptake by skeletal muscle microvascular endothelial cells from equilibrative nucleoside transporter 1 (ENT1)-null mice: effect of oxidative stress.
    Bone DB; Antic M; Quinonez D; Hammond JR
    Microvasc Res; 2015 Mar; 98():16-22. PubMed ID: 25448155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PMN-derived netrin-1 attenuates cardiac ischemia-reperfusion injury via myeloid ADORA2B signaling.
    Li J; Conrad C; Mills TW; Berg NK; Kim B; Ruan W; Lee JW; Zhang X; Yuan X; Eltzschig HK
    J Exp Med; 2021 Jun; 218(6):. PubMed ID: 33891683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blockade of equilibrative nucleoside transporter 1/2 protects against Pseudomonas aeruginosa-induced acute lung injury and NLRP3 inflammasome activation.
    Chambers ED; White A; Vang A; Wang Z; Ayala A; Weng T; Blackburn M; Choudhary G; Rounds S; Lu Q
    FASEB J; 2020 Jan; 34(1):1516-1531. PubMed ID: 31914698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Signaling through hepatocellular A2B adenosine receptors dampens ischemia and reperfusion injury of the liver.
    Zimmerman MA; Grenz A; Tak E; Kaplan M; Ridyard D; Brodsky KS; Mandell MS; Kam I; Eltzschig HK
    Proc Natl Acad Sci U S A; 2013 Jul; 110(29):12012-7. PubMed ID: 23812746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting Drug Interactions with Human Equilibrative Nucleoside Transporters 1 and 2 Using Functional Knockout Cell Lines and Bayesian Modeling.
    Miller SR; Zhang X; Hau RK; Jilek JL; Jennings EQ; Galligan JJ; Foil DH; Zorn KM; Ekins S; Wright SH; Cherrington NJ
    Mol Pharmacol; 2021 Feb; 99(2):147-162. PubMed ID: 33262250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Equilibrative Nucleoside Transporters 1 and 4: Which One Is a Better Target for Cardioprotection Against Ischemia-Reperfusion Injury?
    Yang C; Leung GP
    J Cardiovasc Pharmacol; 2015 Jun; 65(6):517-21. PubMed ID: 26070128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of human equilibrative nucleoside transporters by 4-((4-(2-fluorophenyl)piperazin-1-yl)methyl)-6-imino-N-(naphthalen-2-yl)-1,3,5-triazin-2-amine.
    Tang PCT; Yang C; Li RW; Lee SM; Hoi MP; Chan SW; Kwan YW; Tse CM; Leung GP
    Eur J Pharmacol; 2016 Nov; 791():544-551. PubMed ID: 27388143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nucleoside Reverse Transcriptase Inhibitor Interaction with Human Equilibrative Nucleoside Transporters 1 and 2.
    Miller SR; Hau RK; Jilek JL; Morales MN; Wright SH; Cherrington NJ
    Drug Metab Dispos; 2020 Jul; 48(7):603-612. PubMed ID: 32393653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.